Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Menopause. 2010 May–Jun;17(3):594–601. doi: 10.1097/gme.0b013e3181c92134

FIGURE 1. Participant Screening and Enrollment Flow Chart.

FIGURE 1

Transvaginal ultrasound (TVU), lost-to-follow-up (LTFU)

We excluded 13 women at UCD from this analysis because they did not meet entry criteria and were deemed protocol violators (11 due to a thickened endometrium, 1 with breast cancer, 1 without a baseline blood sample). In addition, 13 women (11 at UCD, 2 at ISU) had missing body composition data at 6 and/or 12 month (mo) time points because they were lost to follow-up and thus excluded from the analysis. Three women discontinued treatment, but completed the trial; their data were included in the analysis.